Jeff Johnson
Stock Analyst at Baird
(3.14)
# 490
Out of 5,218 analysts
152
Total ratings
65.93%
Success rate
37.09%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Patterson Cos | Maintains: Neutral | 25 31 | 31.05 | -0.16% | 7 | Dec 12, 2024 | |
Tandem Diabetes Care | Maintains: Neutral | 39 37 | 32.68 | 13.22% | 14 | Nov 7, 2024 | |
Envista Holdings | Maintains: Neutral | 17 22 | 19.49 | 12.88% | 7 | Oct 31, 2024 | |
Stryker | Maintains: Outperform | 378 405 | 375.05 | 7.99% | 11 | Oct 30, 2024 | |
Align Tech | Maintains: Outperform | 325 276 | 235.25 | 17.32% | 16 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 118 125 | 94.91 | 31.7% | 15 | Aug 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 104 110 | 84.14 | 30.73% | 8 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 155 145 | 106.86 | 35.69% | 13 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 92 82 | 76.59 | 7.06% | 9 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 80 82 | 77.21 | 6.2% | 12 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 180 238 | 269.59 | -11.72% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 67 70 | 46.2 | 51.52% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 53 61 | 18.26 | 234.06% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 78 67 | 19.75 | 239.24% | 6 | Feb 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 | n/a | n/a | 7 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 178 | n/a | n/a | 6 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 31 | n/a | n/a | 3 | Nov 11, 2019 |